| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/10/2009 | US7488711 Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth |
| 02/10/2009 | US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 02/10/2009 | US7488597 Polynucleotide encoding an intracellular estradiol binding protein |
| 02/10/2009 | US7488590 Fusion of Fc domains with biologically active peptides; selecting peptide that modulates the activity of AGP-3, preparing a gene construct; expressing the pharmacologically active compound in which an Fc domain is covalently linked to peptide |
| 02/10/2009 | US7488589 Interferon-alpha polypeptides and conjugates |
| 02/10/2009 | US7488588 Compounds related to or derived from GFR α4 and their use |
| 02/10/2009 | US7488587 Nucleic acid; use identifying the enzyme inhibitors which are used as antitumor agents; detection of cells expressing the enzyme |
| 02/10/2009 | US7488488 Polypeptide, polynucleotide, vector, transformant, antibody, vaccine, and receptor binding assay; miticide vaccines or prophylactic and preventitive vaccines for piroplasmosis, Q fever, or viral encephalitis |
| 02/10/2009 | US7488481 Polypeptides derived from anti-HIV-1 gp120 antibodies that abrogate gp120 binding to CCR5 |
| 02/10/2009 | US7488479 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 02/10/2009 | US7488478 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis |
| 02/10/2009 | US7488477 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 02/10/2009 | US7488473 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide |
| 02/10/2009 | US7488316 Improved delivery of drug formulations, protein drugs, from implanted medical devices, drug is stored as a solid or in concentrated, rather than dilute, solutions; decreased time required for dose of a drug formulation to be released from device; inhibition of gelation, aggregation, or precipitation |
| 02/10/2009 | CA2458067C Use of flibanserin in the treatment of sexual disorders |
| 02/10/2009 | CA2358448C Dispersible concentrate for the delivery of cyclosporin |
| 02/10/2009 | CA2344086C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 02/10/2009 | CA2339299C Method of modulating memory effector t-cells and compositions |
| 02/10/2009 | CA2329776C Antibody against lar phosphatase subunit |
| 02/10/2009 | CA2286671C Method and formulation for treating vascular disease |
| 02/10/2009 | CA2186511C Pyrimidinyl derivatives as interleukin inhibitors |
| 02/10/2009 | CA2166318C Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 02/10/2009 | CA2165197C Recombinant stratum corneum chymotryptic enzyme (scce) |
| 02/10/2009 | CA2138558C Use of r-(+)-.alpha.-lipoic acid, r-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae |
| 02/05/2009 | WO2009018493A1 A micro-rna family that modulates fibrosis and uses thereof |
| 02/05/2009 | WO2009018484A1 Compositions for delivery of biologically active agents to surfaces |
| 02/05/2009 | WO2009018477A2 Methods of inhibiting calcineurin with apoe analogs |
| 02/05/2009 | WO2009018429A2 TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-α2 |
| 02/05/2009 | WO2009018333A2 Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells |
| 02/05/2009 | WO2009018179A2 Cyclophilin d-amyloid beta interaction potentiates mitochondrial dysfunction in a transgenic mouse model of alzheimer's disease |
| 02/05/2009 | WO2009018175A2 Cyclic azapeptides as integrin markers |
| 02/05/2009 | WO2009018010A1 Methods for the treatment or prevention of hemorrhagic conditions |
| 02/05/2009 | WO2009017775A2 Process for the preparation of a polypeptide |
| 02/05/2009 | WO2009017742A1 Multifunctional and combinational application of aspartame and or futhan |
| 02/05/2009 | WO2009017714A1 Use of erythropoietin to develop small molecule inhibitors of janus kinase-2 |
| 02/05/2009 | WO2009017655A2 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof |
| 02/05/2009 | WO2009017646A2 Compositions comprising human collagen and human elastin and methods for soft tissue augmentation |
| 02/05/2009 | WO2009017620A1 Chemokine analogs |
| 02/05/2009 | WO2009017482A1 Collagen-related peptides |
| 02/05/2009 | WO2009017255A1 Method for specific regulation of toll-like receptor/interleukin-18 signaling by mutation-introduced myd88 protein |
| 02/05/2009 | WO2009016855A1 Method of preventing hair loss and method of preventing hair depigmentation |
| 02/05/2009 | WO2009016384A2 Gsk-3 inhibitors |
| 02/05/2009 | WO2009016333A1 Osteogenic compounds |
| 02/05/2009 | WO2009016131A1 Complexes between an amphiphilic polymer and an osteogenic protein of the bmps family |
| 02/05/2009 | WO2009015841A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | WO2009015840A2 Polypeptide for targeting of neural cells |
| 02/05/2009 | WO2009015456A1 Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray |
| 02/05/2009 | WO2009007661A3 Use of a chromatography substrate for reducing the amount of adamts13 in a solution derived from plasma |
| 02/05/2009 | WO2008149320A3 Slow release pharmaceutical composition made of microparticles |
| 02/05/2009 | WO2008145865A3 Mutated hyperthermophilic phosphotriesterases and uses thereof |
| 02/05/2009 | WO2008145850A3 Use of an active ingredient derived from amaranth (amaranthus hypochondriacus) for preparing a composition for protecting mitochondria |
| 02/05/2009 | WO2008144019A3 Suppression of allergic inflammation by ascaris heme-binding protein (hbp) |
| 02/05/2009 | WO2008141786A3 Peptides having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases |
| 02/05/2009 | WO2008140602A3 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN |
| 02/05/2009 | WO2008137720A3 Peptide analogs that are potent and selective for human neurotensin receptor subtype 2 |
| 02/05/2009 | WO2008104203A3 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 02/05/2009 | WO2008076939A3 Human cancer therapy using engineered matrix metalloproteinase-activated anthrax lethal toxin that targets tumor vasculature |
| 02/05/2009 | WO2008059043A3 Combination of coagulation factor viii with apc-resistant factor v |
| 02/05/2009 | WO2008005686A8 Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye |
| 02/05/2009 | WO2006027780A3 Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same |
| 02/05/2009 | US20090038023 Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them |
| 02/05/2009 | US20090038022 IGF-1 Novel peptides |
| 02/05/2009 | US20090036656 Method for preparing a biomaterial |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036417 Cochleates without metal cations as bridging agents |
| 02/05/2009 | US20090036385 Hair care preparation |
| 02/05/2009 | US20090036384 Increasing pregnancy rates |
| 02/05/2009 | US20090036383 Compositions and methods for promoting lipid mobilization in humans |
| 02/05/2009 | US20090036382 TGF-Beta Modulators and Use Thereof |
| 02/05/2009 | US20090036381 Treatment of diabetes |
| 02/05/2009 | US20090036380 Composition And Method For Brain Tumor Therapy |
| 02/05/2009 | US20090036379 Inhibitors of proteins from the rho-gef family |
| 02/05/2009 | US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis |
| 02/05/2009 | US20090036377 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells |
| 02/05/2009 | US20090036376 Treatment for Anxiety |
| 02/05/2009 | US20090036375 DBC1, a novel native inhibitor of anti-aging protein SIRT1 |
| 02/05/2009 | US20090036374 Hepatocyte growth factor receptor splice variants and methods of using same |
| 02/05/2009 | US20090036373 a Wnt pathway stimulator and a Tie2 pathway repressor; polypeptides |
| 02/05/2009 | US20090036372 treating obesity, diabetes, inflammation, or cancer in a mammal with a biosynthesized protein from culturing microorganisms of algae or bacteria; viral infections, oxidative stress, cardiovascular diseases, immune system disorders, metabolic disorders, HIV, or gastric reflux disease |
| 02/05/2009 | US20090036371 Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents |
| 02/05/2009 | US20090036370 Leukocyte Adhesion Inhibitor-1 (LAI-1) |
| 02/05/2009 | US20090036369 Anti-tumor agents comprising r-spondins |
| 02/05/2009 | US20090036368 Therapeutic Combination |
| 02/05/2009 | US20090036367 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 02/05/2009 | US20090036366 Inhibitors of human plasmin derived from the kunitz domains |
| 02/05/2009 | US20090036365 Inhibitors of human plasmin derived from the kunitz domains |
| 02/05/2009 | US20090036364 Gip analog and hybrid polypeptides with selectable properties |
| 02/05/2009 | US20090036363 Peptides as cell penetrating carriers |
| 02/05/2009 | US20090036362 Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof |
| 02/05/2009 | US20090036361 Use of Blood Coagulation Factor XIII for Treating Hemophilia A |
| 02/05/2009 | US20090036360 Medicament containing activated antithrombin iii |
| 02/05/2009 | US20090036359 Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses |
| 02/05/2009 | US20090036358 Methods of preparing pharmaceutical compositions for treatment of factor Vlll associated disorders and methods of use |
| 02/05/2009 | US20090036357 Azapeptide derivatives |
| 02/05/2009 | US20090036356 Octanoic acid derivatives as dipeptidyl peptidase inhibitors |
| 02/05/2009 | US20090036355 Antisense Modulation of PTP1B Expression |
| 02/05/2009 | US20090036354 Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| 02/05/2009 | US20090036353 Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers |
| 02/05/2009 | US20090036352 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 02/05/2009 | US20090036351 Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |